4
Changes in Ownership
GENELUX Corp Filed Acc 0001209191-23-046883
VP, Pharmaceutical Development sold 3,265 shares at $23.73 ($77,478)
From the SEC's structured data for this filing
Trades in this filing
Cappello Joseph · VP, Pharmaceutical Development
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-08-18 | Sale : show line 1 in the form | −3,265 | $23.73 | $77,478 | 5,735 | D |
| Open-market sales · 3,265 sh · avg $23.73 · $77,478 | ||||||
Loading xslF345X05/doc4.xml…